![]() |
|
|
Vol. 302, Issue 3, 983-991, September 2002
Departments of Neuroscience and Psychiatry, McKnight Brain
Institute, University of Florida, Gainesville, Florida (S.T.S., P.B.);
and Neurobiological Psychiatry Unit, McGill University, Montreal,
Quebec, Canada (S.T.S.)
YM992
[(S)-2-[[(7-fluoro-4-indanyl)oxy]methyl]morpholine
monohydrochloride] is a selective serotonin
(5-hydroxytryptamine; 5-HT) reuptake inhibitor (SSRI) and a potent
5-HT2A antagonist. The aim of the present study was to
assess, using in vivo extracellular unitary recordings, the effect of
acute and sustained administration of YM992 (40 mg kg
1
day
1 s.c., using osmotic minipumps) on the spontaneous
firing activity of locus coeruleus (LC) norepinephrine (NE) neurons.
Acute intravenous injection of YM992 (4 mg kg
1)
significantly decreased NE neuron firing activity by 29% and blocked
the inhibitory effect of a subsequent injection of the 5-HT2 agonist DOI
[1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride]. A
2-day treatment with YM992 decreased the firing rate of NE neurons by
66%, whereas a partial recovery was observed after a 7-day treatment
and a complete one after a 21-day treatment. Following the injection of
the
2-adrenoceptor antagonist idazoxan (1 mg
kg-1 i.v.), NE neuron firing was equalized in controls and
2-day YM992-treated rats. This put into evidence an increased degree of
activation of
2-adrenergic autoreceptors in the treated
rats. The suppressant effect of the
2-adrenoceptor
agonist clonidine was significantly decreased in long-term
YM992-treated rats. The recovery of LC firing activity after long-term
YM992 administration could thus be explained by a decreased sensitivity
of
2-adrenergic autoreceptors. Sustained SSRI
administration leads to a gradual reduction of the firing activity of
NE neurons during long-term administration, whereas YM992 produced
opposite effects. The exact basis for the increased synaptic
availability of NE by YM992 remains to be elucidated. This NE activity,
resulting from 5-HT reuptake inhibition plus 5-HT2A
receptor antagonism, might confer additional benefits in affective and
anxiety disorders.
This article has been cited by other articles:
![]() |
A. E. Dorr and G. Debonnel Effect of Vagus Nerve Stimulation on Serotonergic and Noradrenergic Transmission J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 890 - 898. [Abstract] [Full Text] [PDF] |
||||